QA: XOMA Royalty Corp in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000791908_2022_XOMA_Royalty_Corp.pdf

Logs

info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME (unaudited) (calc 2)': 2, '00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME': 12}}

Graph

Absolute values for 0000791908, XOMA Royalty Corp

  xvar xval
0 AssetsCurrent 96,973,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 13,000
3 remainder_Assets 69,576,000
4 LiabilitiesCurrent 12,967,000
5 LiabilitiesNoncurrent 34,000
6 remainder_Liabilities 11,685,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 19,460,454
9 ResearchAndDevelopmentExpense 171,265
10 remainder_Expenses 526,030
11 remainder_Revenues 34,030,956
12 remainder_NetIncome -266,684
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 166,562,000
1 Liabilities 24,686,000
2 Expenses 20,157,749
3 Revenues 34,030,956
4 StockholdersEquity 141,876,000
5 NetIncome 13,606,523
6 ComprehensiveNetIncome 13,606,523
7 BaseVar 122,851,694
8 EconomicCapitalRatiobeforeLimitedLiability 3.38
9 EconomicCapitalRatio 3.94

Edgar->Model Mapping

Feature Distribution

Change over Time